Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Copell Watson Insider Profile
4 Followers
Daniel Copell Watson, Chief Revenue Oficer at Beauty Health, holds 808.62K shares in Beauty Health (Ticker: SKIN).
Daniel Copell Watson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Daniel Copell Watson's holdings
Insider Roles
Chief Revenue Oficer
Roles that Daniel Copell Watson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Daniel Copell Watson
Daniel Copell Watson's Trading History
List of latest transactions for each holding click on a transaction to see Daniel Copell Watson's performance on stock
You May Also Like
Daniel Copell Watson insider profile FAQ
What is the percentage of profitable transactions made by Daniel Copell Watson?
The percentage of profitable transactions made by Daniel Copell Watson is ―.
What is the average return per transaction made by Daniel Copell Watson?
The average return per transaction made by Daniel Copell Watson is ―.
What stocks does Daniel Copell Watson hold?
Daniel Copell Watson holds: SKIN stocks.
What was Daniel Copell Watson’s latest transaction?
Daniel Copell Watson latest transaction was an Uninformative Buy of ―.
What was Daniel Copell Watson's most profitable transaction?
Daniel Copell Watson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daniel Copell Watson's role in Beauty Health?
Daniel Copell Watson's role in Beauty Health is Chief Revenue Oficer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.